These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

296 related items for PubMed ID: 9039923

  • 1. Superiority of sirolimus (rapamycin) over cyclosporine in augmenting allograft and xenograft survival in mice treated with antilymphocyte serum and donor-specific bone marrow.
    Hale DA, Gottschalk R, Fukuzaki T, Wood ML, Maki T, Monaco AP.
    Transplantation; 1997 Feb 15; 63(3):359-64. PubMed ID: 9039923
    [Abstract] [Full Text] [Related]

  • 2. Determination of an improved sirolimus (rapamycin)-based regimen for induction of allograft tolerance in mice treated with antilymphocyte serum and donor-specific bone marrow.
    Hale DA, Gottschalk R, Maki T, Monaco AP.
    Transplantation; 1998 Feb 27; 65(4):473-9. PubMed ID: 9500619
    [Abstract] [Full Text] [Related]

  • 3. Use of CTLA4-Ig in combination with conventional immunosuppressive agents to prolong allograft survival.
    Hale DA, Gottschalk R, Maki T, Monaco AP.
    Transplantation; 1997 Sep 27; 64(6):897-900. PubMed ID: 9326417
    [Abstract] [Full Text] [Related]

  • 4. Induction of tolerance to skin allografts by intrathymic injection of donor splenocytes. Effect of donor-recipient strain combination and supplemental rapamycin.
    Dono K, Maki T, Wood ML, Monaco AP.
    Transplantation; 1995 Dec 15; 60(11):1268-73. PubMed ID: 8525521
    [Abstract] [Full Text] [Related]

  • 5. Late adjunctive therapy with single doses of rapamycin in skin-allografted mice treated with antilymphocyte serum and donor bone marrow cells.
    De Fazio SR, Plowey JM, Hartner WC, Gozzo JJ.
    Transpl Immunol; 1996 Jun 15; 4(2):105-12. PubMed ID: 8843586
    [Abstract] [Full Text] [Related]

  • 6. Indefinite survival of skin allografts in adult thymectomized, antilymphocyte serum-treated mice given bone marrow and thymus grafts of donor origin: tolerance induction by donor bone marrow and thymus.
    Fukuzaki T, Hancock WW, Monaco AP, Maki T.
    Transplantation; 1998 Apr 27; 65(8):1036-43. PubMed ID: 9583862
    [Abstract] [Full Text] [Related]

  • 7. Extended skin allo- and xenograft survival in mice treated with rapamycin, antilymphocyte serum, and donor-specific bone marrow transfusion.
    Hale DA, Gottschalk R, Fukuzaki T, Wood ML, Maki T, Monaco AP.
    Transplant Proc; 1996 Dec 27; 28(6):3269. PubMed ID: 8962269
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Use of pharmacologic immunosuppression to augment the specific unresponsiveness (tolerance) to skin allografts induced by donor-specific bone marrow in antilymphocyte serum-treated mice: the unique effect of sirolimus.
    Hale D, Gottschalk R, Maki T, Monaco AP.
    Transplant Proc; 1998 Aug 27; 30(5):2432-4. PubMed ID: 9723527
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. The effect of antilymphocyte serum, fractionated donor bone marrow, and cyclosporine on renal allograft survival in mongrel dogs.
    Hartner WC, Markees TG, De Fazio SR, Khouri W, Maki T, Monaco AP, Gozzo JJ.
    Transplantation; 1991 Nov 27; 52(5):784-9. PubMed ID: 1835194
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Active role of chimerism in transplantation tolerance induced by antilymphocyte serum, sirolimus, and bone-marrow-cell infusion.
    Kanamoto A, Monaco AP, Maki T.
    Transplantation; 2004 Sep 27; 78(6):825-30. PubMed ID: 15385800
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Potent skin allograft survival prolongation using a committed progenitor fraction of bone marrow in mice.
    Akpinar E, Craighead N, Smoot D, Hale DA.
    Transplantation; 2004 Aug 15; 78(3):383-91. PubMed ID: 15316366
    [Abstract] [Full Text] [Related]

  • 17. Effect of posttransplantation administration of peripheral blood lymphocytes in skin-grafted mice treated with antilymphocyte serum or antilymphocyte serum plus bone marrow.
    De Fazio SR, Hartner WC, Monaco AP, Gozzo JJ.
    Transplantation; 1987 Jul 15; 44(1):70-5. PubMed ID: 3299924
    [Abstract] [Full Text] [Related]

  • 18. Targeted T-cell depletion or CD154 blockade generates mixed hemopoietic chimerism and donor-specific tolerance in mice treated with sirolimus and donor bone marrow.
    Anam K, Akpinar E, Craighead N, Black AT, Hale DA.
    Transplantation; 2004 Nov 15; 78(9):1290-8. PubMed ID: 15548965
    [Abstract] [Full Text] [Related]

  • 19. Suppressor cells in specific unresponsiveness to skin allografts in ALS-treated, marrow-injected mice.
    Wood ML, Monaco AP.
    Transplantation; 1980 Mar 15; 29(3):196-200. PubMed ID: 6444769
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.